Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

As IntraBio works to grow the global treatment market for Aqneursa in Niemann-Pick disease type C, the company is already ...

If approved, levacetylleucine could become the first therapy on the market for ataxia-telangiectasia.

Ataxia has no cure. There are no medications that can specifically treat and cure the symptoms of ataxias. However, medications may ease the symptoms by treating the underlying condition that causes ...

Research into Friedreich ataxia has been hampered by low availability of study participants. Now, a European consortium has released baseline data from a continuing study of 592 patients with ...

Ataxia is the defect in normal movements like walking, speaking, eating swallowing etc. It is caused most commonly by damage to the brain stem or cerebellum that regulates movements. There are over 50 ...

GRAND RAPIDS, Mich. — Twenty years ago, Frederick Pepper, at 60 years old, knew something was wrong. After a misdiagnosis for vertigo, a doctor found what was causing Pepper's unbalance. "That doctor ...

CHINO HILLS, Calif. (KABC) -- A Chino Hills family is living with a grim reality. Very few people know what Ataxia is. The neuro-degenerative condition runs in families, and the symptoms can start ...

Previously, the group investigated two models of dystonia, a different motor disorder, and demonstrated that preventing brainstem neurons from communicating with the cerebellum disturbed sleep. 4 ...

Friedreich ataxia (FA) is a rare, hereditary neurodegenerative disease that causes difficulties with coordination and balance and reduces lifespan. The disease affects approximately 1 in 50,000 people ...

Friedreich’s ataxia is a chronic, progressive neurological condition that leads to impaired muscle coordination. This can affect balance and mobility as well as speech and heart health. Friedreich’s ...